Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

NCT01346293 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3372
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company